XML 67 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Summary of Significant Accounting Policies - Preliminarily Estimates Impact to Consolidated Statement of Operations (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
Revenue Initial Application Period Cumulative Effect Transition [Line Items]                        
Total revenue $ 200.9 $ 191.1 $ 192.7 $ 187.9 $ 199.6 $ 194.7 $ 196.7 $ 178.9 $ 772.6 $ 769.9 $ 740.5 $ 722.5
Selling, general, and administrative expense 121.4 115.1 115.4 115.2 122.1 122.1 120.3 111.9 467.1 476.4 359.2 366.0
Income tax provision 3.0 4.5 (26.3) 4.8 5.8 3.0 6.2 5.6 (14.0) 20.6 38.8 54.5
Net income attributable to Myriad Genetics, Inc. stockholders $ 13.1 $ 9.7 $ 28.7 $ 79.6 $ 12.3 $ 2.8 $ 6.1 $ (0.7) $ 131.1 $ 20.5 $ 117.2 $ 79.8
Earnings per share:                        
Basic $ 0.19 $ 0.14 $ 0.41 $ 1.16 $ 0.18 $ 0.04 $ 0.09 $ (0.01) $ 1.89 $ 0.30 $ 1.67 $ 1.12
Diluted $ 0.18 $ 0.13 $ 0.40 $ 1.13 $ 0.18 $ 0.04 $ 0.09 $ (0.01) $ 1.82 $ 0.30 $ 1.60 $ 1.07
Adjusted for ASC 606 | ASC 606                        
Revenue Initial Application Period Cumulative Effect Transition [Line Items]                        
Total revenue                 $ (28.9) $ (41.2)    
Selling, general, and administrative expense                 (32.1) (36.5)    
Income tax provision                 1.0 (1.6)    
Net income attributable to Myriad Genetics, Inc. stockholders                 $ 2.2 $ (3.1)    
Earnings per share:                        
Basic                 $ 0.03 $ (0.05)    
Diluted                 $ 0.03 $ (0.05)    
As Adjusted | ASC 606                        
Revenue Initial Application Period Cumulative Effect Transition [Line Items]                        
Total revenue                 $ 743.7 $ 728.7    
Selling, general, and administrative expense                 435.0 439.9    
Income tax provision                 (13.0) 19.0    
Net income attributable to Myriad Genetics, Inc. stockholders                 $ 133.3 $ 17.4    
Earnings per share:                        
Basic                 $ 1.92 $ 0.25    
Diluted                 $ 1.85 $ 0.25